Myla was Chairman of the Board at GeneCentric Therapeutics, and Venture Partner at Hatteras Venture Partners. Myla Lai-Goldman joined West Pharmaceutical Services in 2023.
Myla Lai-Goldman is currently
Create your alert
to follow the career of Myla Lai-Goldman.
Myla Lai-Goldman has a Bachelor of Arts in Biology from University of Pennsylvania and a Doctor of Medicine from Columbia University.
They have also studied at University of Pennsylvania :
Find more alumni from University of Pennsylvania
They have also studied at Columbia University :
Find more alumni from Columbia University
Do you need to know more about Myla Lai-Goldman? More results.
Report an error
Update the org chart details of Myla Lai-Goldman.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.